ArticlePLoS neglected tropical diseases2025
Estimating the incidence of dengue in international air travelers from non-endemic countries between 2010-2019.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThere have been increasing numbers of travel-associated dengue cases reported but the true burden is unclear. Existing surveillance in non-endemic countries captures only a fraction of symptomatic cases in returning travelers due to underreporting. Therefore, we used mathematical modeling approaches to account for underreporting and estimate the number of dengue cases occurring during international travel. METHODOLOGY/PRINCIPAL
findingsWe obtained data on numbers of international air passengers from 43 non-endemic "origin" countries, risks of infection while in 119 dengue-endemic locations ("destinations"), and average durations of stay. We estimated travel-associated infections by multiplying the time spent by travelers in endemic countries by the risk of dengue infection and used data on reported cases to infer the fraction of cases that are included in surveillance systems. Our model estimated there were an average of 64,623 (95% CI: 25,068-138,283) symptomatic dengue cases ("cases") and 303,870 (95% CI: 292,841-315,240) total dengue infections (i.e., including symptomatic and asymptomatic infections) across 43 origin countries annually between 2010-19. The USA had the highest number of estimated cases followed by China. Among 34 origin countries that reported dengue cases, the fraction of cases reported varied widely (median 24.9%, range 2.5%-100%). The destination countries where most cases were infected were India, followed by Thailand. CONCLUSIONS/SIGNIFICANCE: We estimated a substantial burden of dengue among international air travelers from 43 non-endemic origin countries. The fraction of cases reported varied widely across origin countries and was also influenced by the specific origin-destination country pair examined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.